已收盘 10-31 16:00:00 美东时间
+0.010
+0.02%
今日重点评级关注:HC Wainwright & Co.:维持Unicycive Therapeutics"买入"评级,目标价从9美元升至22美元;花旗:维持Arcus Biosciences"买入"评级,目标价从54美元升至56美元
10-30 14:22
UBS analyst Joseph Spak maintains Phinia (NYSE:PHIN) with a Neutral and lowers the price target from $62 to $59.
10-30 00:02
2025 Full Year Guidance:The Company updated its full year 2025 guidance, incorporating the expected 2025 performance of the SEM business. Net sales is expected to be in the range of $3.39 billion to $3.45 billion.
10-28 19:32
Phinia (NYSE:PHIN) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.19 by 33.61 percent. This is a 35.9 percent increase over earnings of $1.17 per share from the same period
10-28 19:31
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
PHINIA Inc. ( ($PHIN) ) has issued an update. PHINIA Inc. has entered into a se...
10-22 04:55
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从19美元升至20美元;Ascendiant Capital:维持Plus Therapeutics"买入"评级,目标价从20.5美元升至21美元
10-07 15:04
In the preceding three months, 5 analysts have released ratings for Phinia (NYS...
10-07 05:01